Analytical Data
-
Gene name
TRAPPC2
- Application
-
Alternative Names
MIP-2A; SEDL; SEDT; TRS20; ZNF547L; Sedlin; Spondyloepiphyseal Dysplasia,Late
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P0DI81
-
Expression Region
Met1~Ser140
-
Molecular Weight
18kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TRAPPC2 (Trafficking Protein Particle Complex 2) is a critical component of the TRAPP (Transport Protein Particle) complex, which plays a vital role in the regulation of intracellular trafficking and endosomal function. Mutations in the TRAPPC2 gene are linked to X-linked intellectual disability, emphasizing its significance in neuronal development and function. The study of TRAPPC2 recombinant protein is pivotal for understanding its structural and functional properties, as well as its interactions with other proteins within the TRAPP complex. By producing and characterizing TRAPPC2 as a recombinant protein, researchers can gain insights into its mechanisms of action, analyze how mutations affect protein function, and explore potential therapeutic avenues for TRAPPC2-related disorders. These investigations are essential for elucidating the underlying molecular pathways that contribute to intellectual disabilities and other neurodevelopmental conditions, paving the way for the development of targeted interventions. As our understanding of TRAPPC2 continues to grow, it holds promise for advancing the field of molecular neuroscience and for informing the creation of novel treatment strategies for affected individuals.
